Company / Shares Outstanding
Dyne Therapeutics, Inc. Shares Outstanding History
FY2019-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Shares Outstanding
102.3M
FY2024
5-year range
14.4M / 102.3M
FY2020-FY2024
Trend
+66.5%
vs FY2023
Sector context
#92 of 212
Health Care
What the data says
At 102318629.00, Dyne Therapeutics, Inc.'s shares outstanding ranks #121 of 212 in the Health Care sector. Shares Outstanding has increased for 5 consecutive years, from 2442872.00 in FY2019 to 102318629.00 in FY2024.
Based on SEC 10-K filings.
102318629.00 in FY2024 with a 5-year CAGR of +111.1%.
Increased from 55636505.00 to 102318629.00 over the past 2 years.
Health Care sector context is included.
Shares Outstanding over time
Growth rates
- 3-Year CAGR
- +26.2%
- 5-Year CAGR
- +111.1%
- 10-Year CAGR
- -
Sector benchmark
#121 of 212 in Health CareTop 57% of 212This company 102.3M Sector average 306.3M
▼
-66.6% below sector average
Key checks
Key Insights
- Dyne Therapeutics, Inc.'s shares outstanding has grown for 5 consecutive years.
- In FY2024, shares outstanding increased 66.5% year-over-year.
- Ranks #92 out of 212 companies in the Health Care sector.
- Lowest shares outstanding in the period was in FY2019.
Company context
Key Data Points
- Altman Z-Score 3.40 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Shares OutstandingValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | 102.3M | +66.5% |
| FY2023 | 61.5M | +10.5% |
| FY2022 | 55.6M | +9.3% |
| FY2021 | 50.9M | +253.5% |
| FY2020 | 14.4M | +489.3% |
| FY2019 | 2.4M | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026